Peptides studied in metabolic research contexts — including the incretin analogues retatrutide and semaglutide — supplied for in vitro laboratory use. Every vial is HPLC-tested with a batch certificate in the COA library, stocked in Australia and dispatched the same business day when ordered before 12pm AEST. For in vitro research purposes only.
Metabolic research peptides are incretin-receptor compounds studied in relation to body weight and glucose regulation. This category holds retatrutide, which acts at the GIP, GLP-1 and glucagon receptors at once, and semaglutide, a GLP-1 receptor agonist. Both arrive as freeze-dried powder in sealed glass vials, listed by Australian Research Peptides for in vitro laboratory research.
Related guides: GLP-1, GIP and Glucagon: What the Receptor Names Mean · Retatrutide vs Semaglutide: What Is the Difference? · Retatrutide: What It Is and What the Trials Show · Retatrutide Price in Australia
Retatrutide can be bought in Australia from Australian Research Peptides, in HPLC-tested 10 mg, 20 mg and 30 mg vials of freeze-dried powder sealed in glass, shipped to every state and…
Semaglutide is sold in Australia by Australian Research Peptides as a GLP-1 receptor agonist, one 10 mg vial of the freeze-dried 31-amino-acid peptide, sealed and sent to all states and…
Choose by how many receptors the compound acts on. Semaglutide is single-target, binding the GLP-1 receptor alone; retatrutide is a triple agonist, acting at GIP, GLP-1 and glucagon receptors together, and is listed in three vial strengths where semaglutide has one.
| Compound | Vial strengths listed | Studied in relation to |
|---|---|---|
| Retatrutide | 10 mg, 20 mg, 30 mg | obesity and weight loss |
| Semaglutide | 10 mg | body weight and glucose regulation |